Search
EHA Guidelines on Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults
Chronic myelomonocytic leukemia (CMML) is a disease of the elderly, and by far the most frequent overlap myelodysplastic/myeloproliferative neoplasm in adults.
Read moreFirst Hybrid HOPE meeting in Bangkok, Thailand - a report
Highlights of Past EHA (HOPE) Asia 2022
September 2-3, 2022 – Bangkok, Thailand
Meeting chairs
A Almeida, President, European Hematology Association (EHA)
G Gaidano, Chair Global Outreach Committee, European Hematology Association (EHA)
P Rojnuckarin, President, Thai Society of Hematology (TSH)
S Hongeng, Vice President, Thai Society…
Shining a Light on Blood Cancer
EHA Launches Digital Campaign
In September 2021, the European Hematology Association (EHA) will honor Blood Cancer Awareness Month with an extensive digital campaign.
CarrerasLeaders call two is now open
The second CarrerasLeaders call is open: apply now to the postdoctoral program to empower future leaders in the fight against blood cancers.
Read moreEHA-ISHBT Hematology Tutorial
Date: March 1-3, 2024
Format: In-Person
Location: Hyderabad, India
Chairs: P. K.
Highlights from the SWG
Project groupsPan-European Transfusion Research infrAstructure (PETRA) projectThe European Blood Alliance has provided funding for a health science data project entitled: ‘Towards a Pan-European Transfusion Research infrAstructure (PETRA).
Read moreAdvocacy priorities
The European Union works on countless pieces of legislation and policies that affect the health ecosystem. Some are relevant to most medical disciplines, including hematology—such as the legislation on health data or pharmaceuticals.
Read moreSubstances of Human Origin (SoHO) legislation
EHA’s involvementEHA has been involved in both the evaluation and subsequent revision of the EU legislation on human blood and blood components. The evaluation of these rules, which dated back to 2002, began in 2016.
Read more